Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006 Dec 07; 355(23):2408-17.
View in:
PubMed
subject areas
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Benzamides
Cytarabine
Disease-Free Survival
Female
Follow-Up Studies
Fusion Proteins, bcr-abl
Humans
Imatinib Mesylate
Interferon-alpha
Kaplan-Meier Estimate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Piperazines
Protein-Tyrosine Kinases
Pyrimidines
Survival Analysis
Survival Rate
Treatment Outcome
authors with profiles
Richard A. Larson